Contract Pharma
A record number of personalized medicines were approved by the FDA in 2017. Managing Director, Antti Nurmi, Ph.D., explains how early research provides the crucial evidence needed to conduct clinical trials.
Media Coverage
Advancing Rare Disease Research
